Equity Capital Markets

Company · CIK 1815442

Kymera Therapeutics, Inc.

CIK1815442 (SEC EDGAR)
Industry (SIC)2836 — Biological Products, (No Diagnostic Substances)
Incorporated inDE
Business addressMA
ListedKYMR (Nasdaq)
First annual or quarterly report2020-11-05

Offerings

4 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-282912
ShelfEffective
 2024-10-312026-02-266
333-259955
ShelfEffective
 2021-10-012024-08-205
333-257476
Registered companyFinal prospectus
 2021-06-282021-07-023
333-240264
IPOFinal prospectus
 2020-07-312020-08-216

Filings

22
FiledFilingRegistrationAccession
2026-02-26424B5Shelf takedown 333-2829120001193125-26-073542
2025-12-10424B5Shelf takedown 333-2829120001193125-25-314256
2025-12-08424B5Shelf takedown 333-2829120001193125-25-311268
2025-06-27424B5Shelf takedown 333-2829120001193125-25-151288
2025-06-25424B5Shelf takedown 333-2829120001193125-25-146933
2024-10-31S-3ASRShelf registered 333-2829120001193125-24-248179
2024-08-20424B5Shelf takedown 333-2599550001193125-24-203691
2024-08-19424B5Shelf takedown 333-2599550001193125-24-202805
2024-01-05424B5Shelf takedown 333-2599550001193125-24-003347
2024-01-04424B5Shelf takedown 333-2599550001193125-24-002435
2021-10-01S-3ASRShelf registered 333-2599550001193125-21-289673
2021-07-02424B4Final prospectus 333-2574760001193125-21-207604
2021-06-30EFFECTDeclared effective 333-2574769999999995-21-002616
2021-06-28S-1Registration filed 333-2574760001193125-21-202051
2021-03-17DRSDraft made public 377-044430000950123-21-003587
2020-08-21424B4Final prospectus 333-2402640001193125-20-227121
2020-08-20EFFECTDeclared effective 333-2402649999999995-20-002212
2020-08-17S-1/AAmendment 333-2402640001193125-20-221618
2020-08-13S-1/AAmendment 333-2402640001193125-20-218412
2020-08-05S-1/AAmendment 333-2402640001193125-20-210375
2020-07-31S-1Registration filed 333-2402640001193125-20-206645
2020-06-22DRSDraft made public 377-032350000950123-20-006346

All filings of this company · CSV